Licensing Opportunities

  • Composite Gels and Methods of their Use in Tissue Repair, Drug Delivery, and as Implants
    •
       Ref: E-014-2019 | Updated: Oct 27, 2020 | NICHD
  • Dopamine D3 Receptor Agonist Compounds, Methods of Preparation, Intermediates Thereof, and their Methods of Use...
    •
       Ref: E-077-2019 | Updated: Oct 27, 2020 | NIDA
  • Simian T-Cell Lymphotropic Virus Strain Type 3 (STLV-3) Subtype D Variant, a Highly Divergent STLV-3, for...
    •
       Ref: E-303-2013-2 | Updated: Oct 26, 2020 | Johns Hopkins University
  • Personalized Body Weight Management System Using Monitoring Devices and Mathematical Models of Metabolism
    •
       Ref: E-063-2012-0 | Updated: Oct 23, 2020 | NIDDK
  • Rescue of AAV Production by shRNA Co-transfection
    •
       Ref: E-072-2020-0 | Updated: Oct 23, 2020 | NIDCR
  • T-Cell Therapy Against Patient-Specific Cancer Mutations
    •
       Ref: E-233-2014 | Updated: Oct 19, 2020 | NCI
  • Tau RT-QuIC: Ultrasensitive Assays for the Detection of Tau Seeding Activity Associated with Tauopathies
    •
       Ref: E-015-2017-0 | Updated: Oct 14, 2020 | NIAID
  • Use of the TP5 Peptide for the Treatment of Cancer
    •
       Ref: E-007-2019 | Updated: Oct 6, 2020 | NCI
  • Silica-Coated Nanodiamonds for Imaging and Delivery of Therapeutic Agents
    •
       Ref: E-175-2012 | Updated: Oct 6, 2020 | NCI
  • Use of Acetalax for Treatment of Triple Negative Breast Cancer
    •
       Ref: E-041-2018 | Updated: Sep 25, 2020 | NCI-DTB
  • Platform to Enhance Anti-Tumor Immunity
    •
       Ref: E-053-2019 | Updated: Sep 22, 2020 | NCI
  • Methods for Dagnosing and Treating Mycobacterium tuberculosis (Mtb) Infection through Detection of CD153...
    •
       Ref: E-085-2018-0 | Updated: Sep 21, 2020 | NIAID
  • Antibodies and Methods for the Diagnosis and Treatment of Epstein-Barr Virus Infection
    •    Ref: E-001-2017-0 | Updated: Sep 21, 2020 | NIAID
  • Angiogenesis-Based Cancer Therapeutic
    •
       Ref: E-230-2011 | Updated: Sep 17, 2020 |
  • Fibroblast Growth Factor Receptor 4 (FGFR4) Monoclonal Antibodies and Methods of Their Use
    •    Ref: E-264-2015 | Updated: Sep 16, 2020 | NCI
  • Detection of Novel Endocrine-Disrupting Chemicals in Water Supplies
    •
       Ref: E-269-2011 | Updated: Sep 16, 2020 | NCI
  • A Novel Transgenic Zebrafish Line Reporting Dynamic Epigenetic Changes
    •
       Ref: E-124-2019 | Updated: Sep 16, 2020 | NICHD
  • Modulation of Leucine-rich Repeats and Calponin Homology Domain-containing Protein 4 (Lrch4) Activity for...
    •
       Ref: E-012-2011-0 | Updated: Sep 9, 2020 | NIEHS
  • Hspa2 Knockout Mice for Study of Spermatogenesis and Male Infertility
    •
       Ref: E-052-2011-0 | Updated: Sep 4, 2020 | NIEHS
  • Transgenic Hspa2-Cre Mice for Studying Spermatogenesis and Male Infertility
    •
       Ref: E-290-2011-0 | Updated: Sep 4, 2020 | NIEHS
  • Human Phospho-Serine134 Glucocorticoid Receptor Polyclonal Antibody: Useful for the Characterization of...
    •
       Ref: E-182-2011-0 | Updated: Sep 4, 2020 | NIEHS
  • GLI-Similar 3(GLIS3) Knock Out (KO) Mice as Models to Screen Therapeutics for Diabetes, Polycystic Kidney Disease,...
    •
       Ref: E-303-2011-0 | Updated: Sep 4, 2020 | NIEHS
  • An In-Vitro Cell System Useful For Identification of RORgamma Antagonists
    •
       Ref: E-253-2010-0 | Updated: Sep 4, 2020 | NIEHS
  • RORgamma (RORC) Deficient Mice Which Are Useful for the Study of Lymph Node Organogenesis and Immune Responses
    •
       Ref: E-222-2009-0 | Updated: Sep 4, 2020 | NIEHS
  • Cytochromes P450 CYP2J and CYP2C Polyclonal Antibodies and Recombinant Proteins
    •
       Ref: E-153-2011-0 | Updated: Sep 4, 2020 | NIEHS
  • New Mouse Strain with Conditional Deletion of SMAD7: Analysis of Disease Processes Involving Immunological,...
    •
       Ref: E-040-2010-0 | Updated: Sep 4, 2020 | NIEHS
  • T Cell Receptors (TCRs) Specific for Mutant p53
    •
       Ref: E-135-2019 | Updated: Sep 3, 2020 | NCI
  • Margaric Acid Decreases PIEZO2 Mediated Pain
    •
       Ref: E-081-2020 | Updated: Sep 3, 2020 | NCCIH
  • Method of Neoantigen-Reactive T Cell Receptor (TCR) Isolation from Peripheral Blood of Cancer Patients
    •
       Ref: E-102-2020 | Updated: Sep 3, 2020 | NCI
  • Extremely Rapid Method to Isolate Neoantigen Reactive T Cell Receptors (TCRs)
    •
       Ref: E-061-2020 | Updated: Sep 3, 2020 | NCI
  • Calcium (Ca2+) Flux-Dependent Method to Detect and Isolate Tumor Reactive T Cell Receptors (TCRs)
    •
       Ref: E-168-2018 | Updated: Sep 3, 2020 | NCI
  • Combination of Near Infrared Photoimmunotherapy Targeting Cancer Cells and Host-Immune Activation
    •
       Ref: E-113-2018 | Updated: Aug 24, 2020 | NCI
  • Denoising of Dynamic Magnetic Resonance Spectroscopic Imaging Using Low Rank Approximations in the Kinetic Domain...
    •
       Ref: E-063-2017 | Updated: Aug 24, 2020 | NCI
  • T-cell Receptors Targeting CD20-Positive Lymphomas and Leukemias
    •    Ref: E-152-2020 | Updated: Aug 19, 2020 | NCI
  • High Affinity Nanobodies Targeting B7-H3 (CD276) for Treating Solid Tumors
    •
       Ref: E-185-2019 | Updated: Aug 17, 2020 | NCI
  • Convolutional Neural Networks for Organ Segmentation
    •
       Ref: E-182-2016 | Updated: Aug 17, 2020 | CC
  • Therapeutic Immunotoxins with Increased Half-Life and Anti-Tumor Activity
    •
       Ref: E-179-2019 | Updated: Aug 17, 2020 | NCI
  • Humanized Mouse Model to Study Mesothelin (MSLN) -targeted Cancer Therapeutics: Bl6/TPO Mice
    •
       Ref: E-096-2020 | Updated: Aug 17, 2020 | NCI
  • Gene Therapy for Treatment of CRX-Autosomal Dominant Retinopathies
    •
       Ref: E-008-2020 | Updated: Aug 17, 2020 | NEI
  • Progressive and Multipath Neural Network for Medical Image Segmentation
    •
       Ref: E-109-2017 | Updated: Aug 17, 2020 | NIHCC
  • Compounds that Interfere with the Androgen Receptor Complex
    •
       Ref: E-162-2009 | Updated: Aug 17, 2020 | NCI
  • Learning to Read Chest X-Rays: Recurrent Neural Cascade Model for Automated Image Annotation
    •
       Ref: E-045-2016 | Updated: Aug 16, 2020 | NIH-CC
  • Use of Cucurbitacins and Withanolides for the Treatment of Cancer
    •
       Ref: E-050-2010 | Updated: Aug 13, 2020 | NCI
  • Methods of Producing Thymic Emigrants from Induced Pluripotent Stem Cells
    •
       Ref: E-250-2016 | Updated: Aug 13, 2020 | NCI
  • Method of treating silicosis and other occupational lung diseases
    •
       Ref: E-182-2008 | Updated: Aug 13, 2020 | NCI
  • Mobile Interconnected Evaluation and Learning Software
    •
       Ref: E-224-2017 | Updated: Aug 13, 2020 | NIDA
  • Cell Line for Production of Recombinant Human Tissue Inhibitor of Metalloproteinase-2
    •
       Ref: E-216-2017 | Updated: Aug 13, 2020 | NCI
  • Cancer Vaccine Composed of Oligonucleotides Conjugated to Apoptotic Tumor Cells
    •
       Ref: E-266-2009 | Updated: Aug 13, 2020 | NCI
  • Methods and Compositions for Treating Genetically Linked Diseases of the Eye
    •
       Ref: E-284-2012 | Updated: Aug 13, 2020 | NEI
  • Novel Regulatory B cells for Treatment of Cancer and Autoimmune Disease
    •
       Ref: E-101-2010 | Updated: Aug 13, 2020 | NIA
  • Altering the Immune Hierarchy for Human Immunodeficiency Virus (HIV) Vaccine Development by Targeting V1V2 Regions...
    •
       Ref: E-033-2020 | Updated: Aug 13, 2020 | NCi
  • Lentiviral Vectors with Dual Fluorescence/Luminescence Reporters
    •
       Ref: E-132-2011 | Updated: Aug 12, 2020 | NCI
  • Gene-based Diagnostic Predicts Patient Response to Cancer Immunotherapy
    •
       Ref: E-022-2017 | Updated: Aug 12, 2020 | NCI
  • Diagnostic for Cancer of the Adrenal Glands and Adrenal Cortex
    •
       Ref: E-135-2012 | Updated: Aug 10, 2020 | NCI
  • Monoclonal Antibody Fragments for Targeting Therapeutics to Growth Plate Cartilage
    •
       Ref: E-003-2014 | Updated: Aug 7, 2020 | NICHD
  • Autophagy Modulators For Use in Treating Cancer
    •
       Ref: E-003-2018 | Updated: Aug 6, 2020 | NICHD
  • Self-Assembled Ferritin Nanoparticles Expressing Hemagglutinin as an Influenza Vaccine
    •
       Ref: E-293-2011-0 | Updated: Aug 3, 2020 | NIAID
  • Antisense Oligonucleotides against Cancer Cell Migration and Invasion
    •
       Ref: E-041-2020 | Updated: Jul 21, 2020 | NCI
  • T Cell Receptors Targeting KRAS Mutants for Cancer Immunotherapy/Adoptive Cell Therapy
    •
       Ref: E-175-2016 | Updated: Jul 21, 2020 | NCI
  • Novel One-Well Limiting-Antigen Avidity Enzyme Immunoassay to Detect Recent HIV-1 Infection Using a Multi-subtype...
    •
       Ref: E-522-2013-0 | Updated: Jul 9, 2020 |
  • Reporter Assay for Detection and Quantitation of Replication-Competent Gammaretrovirus
    •
       Ref: E-125-2020 | Updated: Jul 7, 2020 | NCI
  • Aryl Hydantoin Heterocycle Compounds that Target the Androgen Receptor for Prostate Cancer Treatment
    •    Ref: E-169-2018 | Updated: Jul 7, 2020 | NCI
  • Monoclonal Antibodies that Neutralize Norovirus
    •
       Ref: E-226-2011-0 | Updated: Jul 6, 2020 | NIAID
  • Vaccine for Dengue Virus
    •
       Ref: E-171-1988-1 | Updated: Jul 6, 2020 | NIAID
  • Universal Influenza Virus Probes for Enrichment of Influenza Viral Sequences
    •
       Ref: E-032-2018-0 | Updated: Jul 6, 2020 | NIAID
  • Broadly Protective Influenza Vaccine Comprising a Cocktail of Inactivated Avian Influenza Viruses
    •
       Ref: E-033-2018-0 | Updated: Jul 6, 2020 | NIAID
  • A Varicella-Zoster Virus Mutant that is Markedly Impaired for Latent Infection Available for the Development of...
    •
       Ref: E-029-2007-0 | Updated: Jul 6, 2020 | NIAID
  • Neutralizing Monoclonal Antibodies to Botulinum Neurotoxin Type A
    •
       Ref: E-180-2006-0 | Updated: Jul 6, 2020 | NIAID
  • Polyvalent Influenza Virus-Like Particles (VLPs) and Use as Vaccines
    •
       Ref: E-195-2014-0 | Updated: Jul 6, 2020 | NIAID
  • Protein Nanoparticles for Antigen Display in Vaccines
    •
       Ref: E-005-2017-0 | Updated: Jul 6, 2020 | NIAID
  • Monoclonal Antibodies Against Bacillus Anthracis Antigens
    •
       Ref: E-146-2004-0 | Updated: Jul 6, 2020 | NIAID
  • Swine Hepatitis E Virus Available For Use in Diagnosis, Prevention and Treatment of Hepatitis E
    •
       Ref: E-203-1997-0 | Updated: Jul 6, 2020 | NIAID
  • Monoclonal Antibodies Specific for the E2 Glycoprotein of Hepatitis C Virus and Their Use in the Diagnosis,...
    •
       Ref: E-017-2001-0 | Updated: Jul 6, 2020 | NIAID
  • Recombinant Proteins Of A Pakistani Strain Of Hepatitis E And Their Use In Diagnostic Methods And Vaccines
    •
       Ref: E-141-1992-2 | Updated: Jul 6, 2020 | NIAID
  • Diagnostic Reagents And Vaccines For Multiple Genotypes Of Hepatitis C Virus
    •
       Ref: E-120-1993-0 | Updated: Jul 6, 2020 | NIAID
  • Monoclonal Antibodies Against Orthopoxviruses
    •
       Ref: E-145-2004-3 | Updated: Jul 6, 2020 | NIAID
  • Improved CD22 Binders for Effective Immunotherapy Against Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL...
    •
       Ref: E-161-2018 | Updated: Jun 30, 2020 | NCI
  • Mouse Embryo Culture Chamber and Imaging System and Methods of Use
    •
       Ref: E-042-2020 | Updated: Jun 30, 2020 | NEI
  • Inhibition of T Cell Lactate Dehydrogenase (LDH) ex vivo Enhances the Anti-tumor Efficacy of Adoptive T Cell...
    •
       Ref: E-126-2019 | Updated: Jun 25, 2020 | NCI
  • Middle East Respiratory Syndrome Coronavirus Antibodies
    •
       Ref: E-239-2014-0 | Updated: Jun 24, 2020 | NIAID
  • Mitotic Figures Electronic Counting Application for Surgical Pathology
    •
       Ref: E-097-2019 | Updated: Jun 17, 2020 | NCI
  • Automated Cancer Diagnostic Tool of Detecting, Quantifying and Mapping Mitotically-Active Proliferative Cells in...
    •
       Ref: E-038-2019 | Updated: Jun 17, 2020 | NCI
  • Development of Next Generation Antibody Drug Conjugates (ADCs) Against CD276
    •
       Ref: E-145-2019 | Updated: Jun 17, 2020 | NCI
  • Small Molecule Inhibitors of Histone Demethylases for Treating Rhabdomyosarcoma (RMS) and Other Cancers
    •
       Ref: E-023-2019 | Updated: Jun 8, 2020 | NCI
  • Chimeric Adaptor Proteins (CAPs) Containing a Linker for Activation of T Cells (LAT) and a Kinase Domain for Use in...
    •
       Ref: E-210-2018 | Updated: May 19, 2020 | NCI
  • Nanoparticle delivery of lung cancer therapeutic
    •
       Ref: E-159-2014 | Updated: May 18, 2020 | NCI
  • Cannabinoid Receptor Meditating Compounds for Metabolic Disease
    •
       Ref: E-140-2014-0 | Updated: May 18, 2020 | NIAAA
  • T-Cell Receptors Targeting Epstein Barr Virus Latent Membrane Protein 2 for Treatment of Lymphomas and Epithelial...
    •
       Ref: E-121-2020 | Updated: May 8, 2020 | NCI
  • Inducible Activation Nucleic Acid Hybrid Switch for Conditional Generation of Oligonucleotides
    •
       Ref: E-065-2019 | Updated: May 1, 2020 | NCI
  • Induced Pluripotent Stem Cells Derived from Patients with CEP290-associated Ciliopathies and Unaffected Family...
    •
       Ref: E-100-2020 | Updated: Apr 30, 2020 | NEI
  • EGFRvIII Antibodies for the Treatment of Human Cancer
    •
       Ref: E-103-2019 | Updated: Apr 28, 2020 | NCI
  • Combined PIKFYVE and p38 MAP Kinase Inhibition for Treating Cancer
    •    Ref: E-138-2019 | Updated: Apr 20, 2020 | NICHD
  • Peptide Hydrogels for Rate-Controlled Delivery of Therapeutics
    •
       Ref: E-188-2017 | Updated: Apr 20, 2020 | NCI
  • Selective estrogen-receptor modulators (SERMs) confer protection against photoreceptor degeneration
    •
       Ref: E-134-2016 | Updated: Apr 13, 2020 | NEI
  • 3D Vascularized Human Ocular Tissue for Cell Therapy and Drug Discovery
    •
       Ref: E-004-2017 | Updated: Apr 13, 2020 | NEI
  • Photoactivatable Lipid-based Nanoparticles as a Vehicle for Dual Agent Delivery
    •
       Ref: E-482-2013 | Updated: Apr 13, 2020 | NCI
  • Cancer Therapies Using Engineered Monomeric Fc Molecules
    •
       Ref: E-019-2012 | Updated: Apr 13, 2020 | NCI
  • Devices for Improved Tissue Cryopreservation and Recovery
    •
       Ref: E-094-2016 | Updated: Apr 13, 2020 | NEI
  • AngleNav: Micro-Electro-Mechanical Systems (MEMs) Trackers to Facilitate Computed Topography (CT)-Guided Needle...
    •
       Ref: E-158-2017 | Updated: Apr 13, 2020 | NIH-CC
  • Ex-vivo Production of Regulatory B-Cells for Use in Auto-immune Diseases
    •
       Ref: E-036-2012 | Updated: Apr 13, 2020 | NEI

    Pages


    Displaying 1 - 100 of 1134

    Category Index

    Office of Technology Transfer, Office of Intramural Research, National Institutes of Health

    6011 Executive Blvd, Suite 325, Rockville, MD 20852 | Phone: 301-496-7057